Prosight Management, LP Personalis, Inc. Transaction History

Prosight Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.78 - $3.64 $104,429 - $213,551	58,668 New	58,668 $116,000
Q3 2020 Nov 13, 2020	SELL	$13.63 - $24.12 $2.57 Million - $4.55 Million	-188,750 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$7.65 - $14.11 $1.73 Million - $3.19 Million	-225,990 Reduced 54.49%	188,750 $2.45 Million
Q1 2020 May 15, 2020	BUY	$4.75 - $12.41 $38,318 - $100,111	8,067 Added 1.98%	414,740 $3.35 Million
Q4 2019 Feb 14, 2020	BUY	$8.73 - $12.95 $2.54 Million - $3.77 Million	291,459 Added 252.97%	406,673 $4.43 Million
Q3 2019 Nov 14, 2019	BUY	$14.16 - $25.34 $832,154 - $1.49 Million	58,768 Added 104.11%	115,214 $1.69 Million
Q2 2019 Aug 14, 2019	BUY	$27.0 - $30.25 $1.52 Million - $1.71 Million	56,446 New	56,446 $1.53 Million

112

30.1M

10.9K

87.8K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $253M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.